DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20205340

Immune boosting and anti-influenza effects of an Unani decoction in influenza like illness and COVID-19 like epidemics: a rationale approach

Athar P. Ansari, Zaheer Ahmed N., Shameem A. Rather, Towseef A. Rafeeqi, Basharat Saleem Beigh

Abstract


The Unani system of medicine is one of the traditional systems of medicine practised since centuries in many parts of the world including India. At a time when the coronavirus disease 2019 (COVID-19) pandemic is still raging across the globe and there is still no appreciable satisfactory management available with vaccination being the only panacea in the near future, unani medicine chiefly composed of herbal drugs is replete with many classical references for the management of influenza like illness and COVID-19 like epidemics. In Unani medicine, nazla-i-wabāi is referred as influenza for which a decoction containing Behidana (Cydonia oblonga), Unnab (Ziziphus jujuba) and Sapistan (Cordia myxa) are recommended to relieve the clinical features of nazla-i-wabāi and other COVID-19 like epidemics. All the three ingredients of this formulation are also individually used for the treatment of sore throat, cough, septicaemia, fever, dyspnoea, pharyngitis, chest pain etc. Certain scientific studies have validated various pharmacological actions of these drugs as claimed by unani physicians. A concerted rational approach has been attempted to highlight the effect of the unani decoction as to its immune boosting property both as prophylactic and therapeutic use in the treatment of influenza like illness and COVID-19 like epidemics in the light of ancient Unani classics and recent scientific studies.


Keywords


Influenza, COVID-19, Unani decoction, Cydonia oblonga, Ziziphus jujuba, Cordia myxa

Full Text:

PDF

References


Lone AH, Ahmad T, Anwar M, Sofi G, Imam H, Habib S. Perception of health promotion in Unani herbal medicine. J Herb Medic. 2012;2(1):1-5.

Ansari AP, Ahmed ZN, Dar PA. Empirical evidence of animals used in biomedical research in Unani Medicine: An appraisal. Int J Unan Integrat Medic. 2018;2(4):11-3.

Ansari AP, Sana SH, Ansari H. The Concept of Abdāl-i-Adwiya (Drug Substitution/ Therapeutic Interchange) in Unani Medicine: A Critical Appraisal. J. Adv. Res. in Pharmaceutical Sciences and Pharmacology Interventions 2020;3(1):1-11.

Ahmad B, Akhtar J. Unani System of Medicine. Pharmacognosy Reviews 2007;1(2):210-14.

Anonymous. Standard Unani Medical Terminology. New Delhi: Central Council for Research in Unani Medicine, Dept. of AYUSH, Ministry of H & FW, Govt. of India; 2012:123,125-26,128-129,131,134,178.

Ahmad I. Introduction to Al-Umur Al-Tabi’yah (Principles of Human Physiology in Tibb). 1st ed. Delhi: Saini Printers, Pahari Dhiraj; 1980;1:32-5.

Ansari AP, Ahmed NZ, Wadud A, Arif M, Khanday S. Ilaj bil Ghiza (Dietotherapy): A core mode of Unani treatment. J Advanc Resear Pharmaceut Sci Pharmacol Intervent. 2018;2:27-35.

Ashraf MU, Muhammad, Hussain MA, Bukhari SNA. Cydonia oblonga M. A Medicinal Plant Rich in Phytonutrients for Pharmaceuticals. Front Pharmacol. 2016;7(163):1-20.

Jurjani AH. Zakhira Khawarizm Shahi (Urdu translation by Khan HH). Vol. V & VI. New Delhi: Idarah Kitab al-Shifa; 2010:93,94,201.

Sina I. Al-Qanoon fi’l Tib (Urdu translation by Kantoori GH). Vol. IV. New Delhi: Ejaz Publishing House; 2010:1205.

Nikhat S, Fazil M. Overview of Covid-19; its prevention and management in the light of Unani medicine. Sci Tot Environm. 2020;728:1-9.

Majusi AA. Kamil al-Sana (Urdu translation by Kanturi GH). Vol. I, Chapter IV & V. New Delhi: Idarah Kitab al-Shifa; 2010:28:226-7.

Mirza MR, Siddiqi MI. Muslim Contribution to Science. New Delhi: Adam Publishers & Distributors; 2005:193-4.

Parvez A, Ahmed Z, Anwar N, Ahmed K. Razi’s unique approach to Amraz-e-Wabaiya (Infectious Diseases): An overview. Int J Herb Medic. 2016;4 (6):176-8.

Islam A. Origin and Development of Unani Medicine: An analytical study. Intellect Discou. 2018;26(1):23-49.

Razi ABMZ. Kitab al-Hawi (Urdu translation by CCRUM). Vol. 23. New Delhi: Central Council for Research in Unani Medicine, Ministry of H & FW, Govt. of India; 2007:149.

Razi ABMZ. Kitab al-Mansuri (Urdu translation by CCRUM). New Delhi: Central Council for Research in Unani Medicine, Ministry of H & FW, Govt. of India; 1991;329:174-7.

Razi ABMZ. Kitab al-Hawi (Urdu translation by CCRUM). Vol. 15. New Delhi: Central Council for Research in Unani Medicine, Ministry of H & FW, Govt. of India. 2008:124-5.

Zohr AMI. Kitab al-Taisir (Urdu translation by CCRUM). New Delhi: Central Council for Research in Unani Medicine, Ministry of H & FW, Govt. of India. 1986:246.

Khan A. Ikseer-i-Azam (Urdu translation by Kabiruddin M). New Delhi: Idarah Kitab al-Shifa. 2011:210.

Kabeeruddin M. Sharah-i-Asbab. Vol. 1, 1st ed. New Delhi: Ejaz Publishing House. 2007:167.

Al-Qamri AMA. Ghina Muna (Urdu translation by CCRUM). New Delhi: Central Council for Research in Unani Medicine, Ministry of H & FW, Govt. of India. 2008:121.

Khan A. Haziq. Lahore: Shaikh Mohammad Bashir and Sons; YNM. 52-3.

Cunha BA. Swine Influenza (H1N1) Pneumonia: Clinical Considerations. Infect Dis Clin N Am. 2010;24:203-28.

25. Wikramaratna PS, Gupta S. Influenza outbreaks. Cell Microbiol. 2009;11(7):1016-24.

Viboud C, Simonsen L, Fuentes R, Flores J, Miller MA, Chowell G. Global Mortality Impact of the 1957–1959 Influenza Pandemic. J Infect Diseas. 2016;213:738-45.

Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA. 2009 H1N1 Influenza. Mayo Clin Proc. 2010; 85(1):64-76.

Webster RG, Govorkova EA. Continuing challenges in influenza. Ann N Y Acad Sci. 2014;1323(1):115-39.

Wiselka M. Influenza: diagnosis, management, and prophylaxis. Brit Med J. 1994;308:1341-5.

Goh KJ, Choong MCM, Elisabeth HT, Cheong EHT, Kalimuddin S, Wen SD et al. Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from COVID-19 Infection. Ann Acad Med Singap. 2020;49(3):108-18.

World Health Organization. Weekly Operational Update on COVID-19. Available at: www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed on 11 September 2020.

COVID-19 pandemic by country and territory. Available at: www.en.m.wikipedia.org. Accessed on 11 September 2020.

Ministry of Health and Family Welfare, Govt. of India. COVID- 19 India. Available at: www.mohfw.gov.in. Accessed on 11 September, 2020.

Statistica, Coronavirus (COVID-19) death rates worldwide as of August 6, 2020, by country. Available at: https://www.statista.com/statistics/1105914/coronavirus-death-rates-worldwide. Accessed on 06 August 2020.

Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-New Coronavirus (SARS-CoV-2): A review and perspective. Int J Biologic Sci. 2020;16(10):1708-17.

Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agen. 2020;12:43.

Li H, Liu S, Yu X, Tang S, Tang C. Coronavirus disease 2019 (COVID-19): Current status and future perspectives. Int J Antimicrob Agent. 2020;20:54.

Islam A, Ahmed A, Naqvi IH, Parveen S. Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019–2020. Virus Dis. 2020.

Ahn JY, Sohn Y, Lee SH, Cho Y, Hyun JH, Baek YJ et al. Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea. J Korean Med Sci. 2020;35 (14):e149.

Ghani N. Khazain al-Adwiya. Vol. II. New Delhi: Central Council for Research in Unani Medicine, Ministry of H & FW, Govt. of India. 2010:480.

Kabiruddin M. Makhzan al-Mufridat. Lahore: Seikh Mohammad Bashir & Sons; YNM. 140,334,403-4.

Khan A. Muheet-i-Azam (Urdu translation by CCRUM). Vol. I. New Delhi: Central Council for Research in Unani Medicine, Ministry of H & FW, Govt. of India. 2012:816-7.

Khare CP. Indian Medicinal Plants. New York: Springer Science + Business Media, LLC. 2007:173;190-1.

Said, M. Hamdard Pharmacopoeia of Eastern Medicine. 2nd ed. Delhi: Sri Satguru Publications; 1997:51,75,102,135,155,1712,177,179,181,204,247-8.

Silva BM, Andrade PB, Valentao P, Ferreres F, Seabra RM, Ferreira MA. Quince (Cydonia oblonga Mill.) fruit (pulp, peel, and seed) and jam: Antioxidant activity. J Agric Food Chem. 2004;52 (15):4705-12.

Magalhaes AS, Siva BM, Pereira JA, Andrade PB, Valentao P, Carvalho M. Protective effect of Quince (Cydonia oblonga Mill.) fruit against oxidative haemolysis of human erythrocytes. Food Chem Toxicol. 2009;47:1372-7.

Baars EW, Jong MC, Boers I, Nierop AFM, Savelkoul HFJ. A comparative in vitro study of the effects of separate and combined products of Citrus e fructibus and Cydonia e fructibus on immunological parameters of seasonal allergic rhinitis. Mediat Inflammat. 2012:1-10.

Hamauzu Y, Yasui H, Inno T, Kume C, Omanyuda M. Phenolic profile, antioxidant property, and anti-influenza viral activity of Chinese quince (Pseudocydonia sinensis Schneid.), quince (Cydonia oblonga Mill.), and apple (Malus domestica Mill.) fruits. J Agric Food Chem. 2005;53(4):928-34.

Ibn Baitar. Al-Jame al-Mufradat al-Adwiya va al-Aghzia (Urdu translation by CCRUM). Vol. III. New Delhi: Central Council for Research in Unani Medicine, Dept. of AYUSH, Ministry of H & FW, Govt. of India. 1999:23:314.

Chen J, Liu X, Li Z, Qi A, Yao P, Zhou Z et al. A Review of Dietary Ziziphus jujuba Fruit (Jujube): Developing Health Food Supplements for Brain Protection. Eviden Base Complement Alternat Medic. 2017:1-10.

Goswami P, Banerjee R, Mukherjee A. Potential antigenotoxicity assessment of Ziziphus jujuba fruit. Heliyon 2019;5(e01768):1-11.

Khan A. Muheet-i-Azam (Urdu translation by CCRUM). Vol. III. New Delhi: Central Council for Research in Unani Medicine, Ministry of H & FW, Govt. of India. 2014:32-34:604-6.

Al-Maghrabi ASI. Kitab al-Fatah fi’l Tadawi Min Jamee Sunuf al-Amraz wa al-Shaksawi (Urdu translation by Bari A). Delhi: NCPC Printers; 2007: 170:178-9.

Bai L, Zhang H, Liu Q, Zhao Y, Cui X, Guo S et al. Chemical characterization of the main bioactive constituents from fruits of Ziziphus jujuba. Food Funct 2016;7(6):2870-7.

Mohebbati R, Bavarsad K, Rahimi M, Rakhshandeh H, Khajavi Rad A, Shafei MN. Protective effects of long-term administration of Ziziphus jujuba fruit extract on cardiovascular responses in L-NAME hypertensive rats. Avicenna J Phytomed. 2018;8(2): 143-51.

Zhang Li, Liu X, Wang Y, Liu G, Zhang Z , Zhao Z et al. In Vitro Antioxidative and Immunological Activities of Polysaccharides from Zizyphus Jujuba Cv. Muzao. Int J Biol Macromol. 2017;95:1119-25.

Eun-Hye H, Jae-Hyoung S, Kang KB, Sung SH, Hyun-Jeong K, Yang H. Anti-influenza activity of betulinic acid from Ziziphus jujuba on Influenza A/PR/8 Virus. Biomol Ther. 2015;23(4):345-9.

Ganachari MS, Kumar S, Bhat KG. Effect of Ziziphus jujuba leaves extract on phagocytosis by human neutrophils. J Natur Remed. 2004;4(1):47-51.

Min-Kyun N, RenBo A, Sang-Myung L, Nam-Doo H, Jae-Kuk Y, Chan-Bok L et al. Screening of crude drugs for antioxidative activity. Korean Journal of Pharmacognosy 2001;32(2):108-15.

Abdel-Aleem ER, Attia EZ, Farag FF, Samy MN, Desoukey SY. Total phenolic and flavonoid contents and antioxidant, anti-inflammatory, analgesic, antipyretic and antidiabetic activities of Cordia myxa L. leaves. Clinic Phytosci. 2019; 5:29:1-9.

Al-Snafi AE. The Pharmacological and therapeutic importance of Cordia myxa- A review. J Pharma. 2016;6(6):47-57.

Ghani N. Khazain al-Adwiya. Vol. IV. New Delhi: Central Council for Research in Unani Medicine, Ministry of H & FW, Govt. of India. 2010:314-7.

Ali WR, Al-Asady ZT, Ibrahim AAJ. Immunomodulatory of Cordia myxa L. aqueous extract fruit in immunized mice with hydatid cyst fluid. J Natur Sci Resear. 2015;5(10):75-83.

Ali KA. Study of effect of alcoholic extract of fruit of Cordia myxa in total count and differential count of white blood cells in rats. AL-Qadisyia J Vet Med Sci. 2008;7(2):21-4.

Al-Bayaty MAA, Al-Tahan FJ. Mechanism of the tracheal smooth muscle relaxant activity of the Cordia myxa plant extract in sheep. Iraq J Veterina Medic. 2008;32(2):214-26.

Anonymous. Guidelines for Unani Practitioners in the wake of COVID-19 pandemic. Central Council for Research in Unani Medicine, Dept. of AYUSH, Ministry of H & FW. Govt. of India; 2020. Available at: https://www.ayush.gov.in/docs/unani-guidelines.pdf. Accessed on 04 September 2020.

Clinical Trials Registry- India. Trial Registered Prospectively. Available at: http://ctri.nic.in/Clinicaltrials/login.php. Accessed on 04 September 2020.

Ghani N. Khazain al-Adwiya. Vol. V. New Delhi: Central Council for Research in Unani Medicine, Ministry of H & FW, Govt. of India. 2010:132-3.

Ansari AP. ‘Ilāj bi’l Tadbīr (Regimenal therapy): a core mode of Unani treatment. J Complement Integr Med. 2020.

Ansari AP, Ahmed ZN, Ahmed KK, Khan AA. An insight on Wabāi Amrād (Epidemic diseases) and COVID-19 like conditions- Unani Perspective. Int J Curre Resear Rev. 2020;12(17):109-19.